A business in context

PCSA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K/A · Current report

    Report date 2026-07-23 · 0001140361-26-038535 · Items 8.01,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001493152-26-038334

  3. 4 · Ownership change

    Report date 2026-08-08 · 0000897069-26-001602

  4. 8-K · Current report

    Report date 2026-07-30 · 0001493152-26-036032 · Items 5.02,5.07,9.01

  5. 4 · Ownership change

    Report date 2026-07-28 · 0001575202-26-000011

  6. 8-K · Current report

    Report date 2026-07-23 · 0001493152-26-035099 · Items 1.01,1.02,2.01,3.02,5.02,5.03,7.01,9.01

  7. 4 · Ownership change

    Report date 2026-07-26 · 0000897069-26-001560

  8. 4 · Ownership change

    Report date 2026-07-26 · 0000897069-26-001558

  9. 4 · Ownership change

    Report date 2026-07-26 · 0000897069-26-001556

  10. 4 · Ownership change

    Report date 2026-07-26 · 0000897069-26-001554

  11. 4 · Ownership change

    Report date 2026-07-26 · 0000897069-26-001552

  12. 4 · Ownership change

    Report date 2026-07-26 · 0000897069-26-001550

  13. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001493152-26-029326

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-021721

  15. 10-K/A · Annual report

    Report date 2025-12-31 · 0001493152-26-020731

  16. 8-K · Current report

    Report date 2026-04-30 · 0001493152-26-020728 · Items 5.02,9.01

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001493152-26-011204

  18. 8-K · Current report

    Report date 2026-02-12 · 0001493152-26-007469 · Items 1.02,9.01

  19. 8-K · Current report

    Report date 2026-01-06 · 0001493152-26-000733 · Items 8.01,9.01

  20. 8-K · Current report

    Report date 2025-12-12 · 0001493152-25-027680 · Items 3.03,5.03,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001493152-25-021069

  22. 8-K/A · Current report

    Report date 2025-09-11 · 0001493152-25-013648 · Items 5.03,5.07,9.01

  23. 8-K · Current report

    Report date 2025-09-11 · 0001493152-25-013108 · Items 5.07,9.01

  24. 8-K · Current report

    Report date 2025-09-10 · 0001493152-25-012966 · Items 5.07

  25. 8-K · Current report

    Report date 2025-09-02 · 0001493152-25-012567 · Items 5.07

  26. 8-K · Current report

    Report date 2025-08-25 · 0001641172-25-025421 · Items 8.01,9.01

  27. 8-K/A · Current report

    Report date 2025-08-04 · 0001641172-25-023736 · Items 1.01,3.02,7.01,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-08-13 · 0001493152-25-011883

  29. 8-K · Current report

    Report date 2025-08-07 · 0001493152-25-011775 · Items 3.01,9.01

  30. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001493152-25-011685

  31. 8-K · Current report

    Report date 2025-08-04 · 0001493152-25-011680 · Items 1.01,3.02,7.01,9.01

  32. 8-K · Current report

    Report date 2025-07-25 · 0001493152-25-011419 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2025-07-18 · 0001493152-25-011305 · Items 5.07,9.01

  34. 8-K · Current report

    Report date 2025-07-15 · 0001641172-25-019663 · Items 5.07

  35. 8-K · Current report

    Report date 2025-06-27 · 0001641172-25-017288 · Items 1.01,7.01,9.01

  36. 8-K · Current report

    Report date 2025-06-24 · 0001641172-25-017185 · Items 1.01,5.07,9.01

  37. 8-K · Current report

    Report date 2025-06-17 · 0001641172-25-015654 · Items 1.01,7.01,9.01

  38. 8-K · Current report

    Report date 2025-06-17 · 0001641172-25-015355 · Items 1.01,7.01,9.01

  39. DEF 14A · Proxy statement

    Report date 2025-05-12 · 0001641172-25-009671

  40. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641172-25-009252

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 5 transaction rows5PSale: 0 transaction rows0SGrant / award: 10 transaction rows10AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

17 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-08
2026-08-11
Ng George KM · Exercise / conversion
Acquired
Common Stock1600.0n/a
2026-08-08
2026-08-11
Ng George KM · Exercise / conversion
Disposed
Restricted Stock
Derivative security
1600.00.0
2026-07-28
2026-07-30
GUJRATHI SHEILAA · Grant / award
Acquired
Series A Preferred Stock
Derivative security
70811.88n/a
2026-07-28
2026-07-30
GUJRATHI SHEILAA · Grant / award
Acquired
Series A Preferred Stock
Derivative security
12311.28n/a
2026-07-26
2026-07-28
Yorke Justin WA · Grant / award
Acquired
Restricted Stock Units
Derivative security
33500.00.0
2026-07-26
2026-07-28
SKIBSTED RUSSELLA · Grant / award
Acquired
Restricted Stock Units
Derivative security
11883.00.0
2026-07-26
2026-07-28
Pannu GeraldineA · Grant / award
Acquired
Restricted Stock Units
Derivative security
33500.00.0
2026-07-26
2026-07-28
Ng George KA · Grant / award
Acquired
Restricted Stock Units
Derivative security
9384.00.0
2026-07-26
2026-07-28
Neal James RA · Grant / award
Acquired
Restricted Stock Units
Derivative security
62221.00.0
2026-07-26
2026-07-28
Lin PatrickA · Grant / award
Acquired
Restricted Stock Units
Derivative security
8450.00.0
2026-07-26
2026-07-28
Guy WendyA · Grant / award
Acquired
Restricted Stock Units
Derivative security
9450.00.0
2026-07-26
2026-07-28
Baluch KhosoA · Grant / award
Acquired
Restricted Stock Units
Derivative security
33500.00.0
2026-07-01
2026-07-01
Ng George KP · Purchase
Acquired
Common Stock3057.01.93
2026-06-30
2026-07-01
Guy WendyP · Purchase
Acquired
Common Stock2436.01.93
2026-06-30
2026-07-01
Lin PatrickP · Purchase
Acquired
Common Stock2106.01.93
2026-06-30
2026-07-01
SKIBSTED RUSSELLP · Purchase
Acquired
Common Stock3277.01.93
2026-06-30
2026-07-01
Young DavidP · Purchase
Acquired
Common Stock2531.01.93

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001533743Processa Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Heatwurx, Inc. · former SEC name · 2011-10-28 to 2017-10-20

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2022-12-31$0$0
2021-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗